
Regenxbio Earnings Preview: What to Expect from RGNX’s Upcoming Report and Potential Negative Numbers
Regenxbio (RGNX): Expectations for the Upcoming Earnings Report Regenxbio, Inc. (RGNX), a clinical-stage biotechnology company focused on developing and commercializing gene therapy products for serious diseases, is set to release its third-quarter earnings report soon. However, recent developments suggest that RGNX might not deliver an earnings beat in its upcoming report. Key Ingredients for an…